Pharmaceuticals Bayer: Science For A Better Life

You need commitment, focus and passion to find new ways to fight the diseases of this world: innovation is at the heart of it.

Partnering

Partnering
orange

Innovation + Partnering

The future of cancer therapy is now
orange

Treatment + Care

Cancer is 100 diseases and each patient is unique
blue

Commitment + Responsibility

We support the EFPIA campaign
#WeWontRest
green

Innovation + Partnering

From molecules to medicine
Drug development: The R&D journey
orange
Cancer

Cancer
blue
Healthy aging

Healthy aging
green
Health policy

Health policy
green

Innovation + Partnering

Open science in cancer research: everybody wins
orange

Argentina

Chagas Disease

“We believe Chagas is a children’s disease”, Dr Jaime Altcheh says, formulating an altogether radical theory about one of the greatest scourges to afflict Latin America.
Social Channels

FaCEBOOK·1 day

#healthyaging… it starts with nutrition. For some extra energy in the morning, try this healthy breakfast recipe. Nuts and seeds are a fantastic source of healthy fats and may help to lower the risk of heart disease. Learn more about #healthyaging here: bit.ly/HealthyBayer

twitter·1 hour

#DYK about 15% of all strokes are caused by bleeding in the brain. #StrokeAwarenessMonth

youtube·5 months

The toughest interview for Clinician Scientists
Visit us on Facebook
Visit us on Twitter
Visit us on YouTube
Bayer sponsored clinical studies

Treatment + Care

Bayer trial finder

www.clinicaltrials.gov

Clinicaltrials.gov

www.clinicalstudydatarequest.com

Data sharing portal

Latest press release

Find us in your country

News

2018-05-17

Bayer highlights latest oncology research at ASCO 2018

2018-05-11

Bayer receives approval for Eylea® in China

2018-05-03

Bayer: Operational business held back by currency effects – Major progress with Monsanto acquisition

2018-04-05

Bayer to showcase data from diverse oncology pipeline at AACR 2018

2018-03-26

Bayer announces completion of rolling submission of New Drug Application in the U.S. for larotrectinib for the treatment of TRK fusion cancer
Press center